title: Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties.
abstract: We report the synthesis of fully biodegradable polymeric nanoparticles presenting mannose residues at their surface and their interaction with lectins. A simple and versatile method was used to reach the surface functionalization of poly(D,L-lactic acid) (PLA) nanoparticles by mannose moieties: It consists in using an amphiphilic mannosylated poly(ethylene oxide)-b-poly(E-caprolactone) (PEO-b-PCL) diblock copolymer as a bioresorbable surface modifier in a simple nanoprecipitation-evaporation procedure. The size and zeta potential of the nanoparticles were found to depend on the molar copolymer/PLA ratio, demonstrating the influence of the copolymer on the formation of the nanoparticles. The bioavailability of the mannose residues as specific recognition sites on the nanoparticle surface could be demonstrated by a modified enzyme-linked lectin assay (ELLA) using biotin-labeled lectins which interact specifically with alpha-D-mannopyrannoside derivatives. Besides specific interaction by lectin-mannose complex formation, nonspecific adsorption of the proteins on the nanoparticle surface was observed. These results were fully supported by isothermal titration calorimetry experiments which suggested that the balance between specific and nonspecific interactions can be controlled by the amount of glycosylated polymer used for the preparation of the nanoparticles. Such nanoparticles are expected to be specifically recognized by mannose receptors, which are highly expressed in cells of the immune system. The targeting properties of these carrier systems combined with their potential adjuvant effects due to their size in the range of 200-300 nm make them attractive candidates as vaccine delivery systems.
authors.affiliation: Centre de Recherches sur les Macromolecules Vegetales (CERMAV-CNRS), Grenoble cedex 9, France. jutta.rieger@upmc.fr
authors.forename: Jutta
authors.initials: J
authors.lastname: Rieger
authors.forename: Hélène
authors.initials: H
authors.lastname: Freichels
authors.forename: Anne
authors.initials: A
authors.lastname: Imberty
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Putaux
authors.forename: Thierry
authors.initials: T
authors.lastname: Delair
authors.forename: Christine
authors.initials: C
authors.lastname: Jérôme
authors.forename: Rachel
authors.initials: R
authors.lastname: Auzély-Velty
mesh_terms: D000327:Adsorption; D001672:Biocompatible Materials / Q000138:chemical synthesis / Q000737:chemistry; D016503:Drug Delivery Systems; D019344:Lactic Acid / Q000138:chemical synthesis / Q000737:chemistry*; D007783:Lactones / Q000138:chemical synthesis / Q000737:chemistry*; D037102:Lectins / Q000737:chemistry; D046911:Macromolecular Substances / Q000138:chemical synthesis / Q000737:chemistry; D008358:Mannose / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry*; D010316:Particle Size; D011091:Polyesters; D011092:Polyethylene Glycols / Q000138:chemical synthesis / Q000737:chemistry*; D011108:Polymers / Q000138:chemical synthesis / Q000737:chemistry*; D013499:Surface Properties; D014612:Vaccines / Q000008:administration & dosage
chemical_list: D001672:Biocompatible Materials; D007783:Lactones; D037102:Lectins; D046911:Macromolecular Substances; D011091:Polyesters; D011108:Polymers; D014612:Vaccines; C473831:poly(ethylene oxide)-b-poly(caprolactone); D019344:Lactic Acid; D011092:Polyethylene Glycols; C033616:poly(lactide); D008358:Mannose